1. Home
  2. NXL vs VHC Comparison

NXL vs VHC Comparison

Compare NXL & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • VHC
  • Stock Information
  • Founded
  • NXL 2010
  • VHC 2005
  • Country
  • NXL United States
  • VHC United States
  • Employees
  • NXL N/A
  • VHC N/A
  • Industry
  • NXL Medical Specialities
  • VHC Multi-Sector Companies
  • Sector
  • NXL Health Care
  • VHC Miscellaneous
  • Exchange
  • NXL Nasdaq
  • VHC Nasdaq
  • Market Cap
  • NXL 31.1M
  • VHC 34.2M
  • IPO Year
  • NXL 2022
  • VHC 1999
  • Fundamental
  • Price
  • NXL $1.94
  • VHC $7.55
  • Analyst Decision
  • NXL Strong Buy
  • VHC
  • Analyst Count
  • NXL 1
  • VHC 0
  • Target Price
  • NXL $5.00
  • VHC N/A
  • AVG Volume (30 Days)
  • NXL 123.3K
  • VHC 6.9K
  • Earning Date
  • NXL 03-14-2025
  • VHC 03-17-2025
  • Dividend Yield
  • NXL N/A
  • VHC N/A
  • EPS Growth
  • NXL N/A
  • VHC N/A
  • EPS
  • NXL N/A
  • VHC N/A
  • Revenue
  • NXL $168,721.00
  • VHC $5,000.00
  • Revenue This Year
  • NXL $175.37
  • VHC N/A
  • Revenue Next Year
  • NXL $334.78
  • VHC N/A
  • P/E Ratio
  • NXL N/A
  • VHC N/A
  • Revenue Growth
  • NXL 52.35
  • VHC N/A
  • 52 Week Low
  • NXL $0.53
  • VHC $3.55
  • 52 Week High
  • NXL $4.49
  • VHC $9.69
  • Technical
  • Relative Strength Index (RSI)
  • NXL 37.77
  • VHC 37.17
  • Support Level
  • NXL $2.16
  • VHC $7.41
  • Resistance Level
  • NXL $2.57
  • VHC $8.92
  • Average True Range (ATR)
  • NXL 0.22
  • VHC 0.66
  • MACD
  • NXL -0.00
  • VHC -0.12
  • Stochastic Oscillator
  • NXL 9.52
  • VHC 12.18

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.

Share on Social Networks: